Immune privilege or inflammation? Insights into the Fas ligand enigma.
作者： Joe O'Connell , Aileen Houston , Michael W. Bennett , Gerald C. O'Sullivan , Fergus Shanahan
DOI: 10.1038/85395
关键词: Fas ligand 、 RNA 、 Immunology 、 Biology 、 Fas Ligand Protein 、 Immune privilege 、 Inflammation
摘要: Fas ligand (FasL) has become an enigmatic molecule: some evidence indicates that it contributes to immune privilege in tissues and tumors, whereas other data demonstrates FasL can elicit inflammation. New findings may begin reconcile the paradoxical effects of FasL.
nature.com
sci-hub.se 参考文章(41)
Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. British Journal of Cancer. ,vol. 82, pp. 1747- 1754 ,(2000) , 10.1054/BJOC.1999.1210
Khong F. Yoong, Simon C. Afford, Satinder Randhawa, Stefan G. Hubscher, David H. Adams, Fas/Fas Ligand Interaction in Human Colorectal Hepatic Metastases: A Mechanism of Hepatocyte Destruction to Facilitate Local Tumor Invasion American Journal of Pathology. ,vol. 154, pp. 693- 703 ,(1999) , 10.1016/S0002-9440(10)65316-3
Almudena Sampalo, Gloria Navas, Francisco Medina, Carmen Segundo, Carmen Cámara, José A. Brieva, Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction. Blood. ,vol. 96, pp. 3168- 3174 ,(2000) , 10.1182/BLOOD.V96.9.3168
Nicholas P. Restifo, Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape Nature Medicine. ,vol. 6, pp. 493- 495 ,(2000) , 10.1038/74955
Hiroyuki Matsue, Keiko Matsue, Michael Walters, Ko Okumura, Hideo Yagita, Akira Takashima, Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells. Nature Medicine. ,vol. 5, pp. 930- 937 ,(1999) , 10.1038/11375
J. W. Streilein, Unraveling Immune Privilege Science. ,vol. 270, pp. 1158- 1158 ,(1995) , 10.1126/SCIENCE.270.5239.1158
Friedemann J. Schaub, David K.M. Han, W. Conrad Liles, Lawrence D. Adams, Scott A. Coats, Ravi K. Ramachandran, Ronald A. Seifert, Stephen M. Schwartz, Daniel F. Bowen-Pope, Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells Nature Medicine. ,vol. 6, pp. 790- 796 ,(2000) , 10.1038/77521
Y Ito, M Monden, T Takeda, H Eguchi, K Umeshita, H Nagano, S Nakamori, K Dono, M Sakon, M Nakamura, M Tsujimoto, M Nakahara, K Nakao, Y Yokosaki, N Matsuura, The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma. British Journal of Cancer. ,vol. 82, pp. 1211- 1217 ,(2000) , 10.1054/BJOC.1999.1065
Han Kyeom Kim, Young-Sik Kim, Ju Han Lee, Insun Kim, Nam Hee Won, Kwang Hee Kim, Jung-Ah Choi, Fas (APO-1/CD95) Ligand and Fas Expression in Renal Cell Carcinomas Archives of Pathology & Laboratory Medicine. ,vol. 124, pp. 687- 693 ,(2000) , 10.5858/2000-124-0687-FACLAF
F Shanahan, G C O'Sullivan, J O'Connell, D Roche, M W Bennett, J K Collins, C Brady, The Fas Counterattack In Vivo: Apoptotic Depletion of Tumor-Infiltrating Lymphocytes Associated with Fas Ligand Expression by Human Esophageal Carcinoma Journal of Immunology. ,vol. 160, pp. 5669- 5675 ,(1998)